Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) is a listed company. Its directors and officers file their transactions with SEDI. Nothing new has been filed by managers of Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) in twelve months, the latest record being from 10 November 2020.
Over the whole record (from 2019), the tally stands at 7 purchases and 1 sale.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
17 of 17 declarations
Cannara Biotech Inc. is a Canadian company focused on the cannabis sector. It was formerly known as Dunbar Capital Corp.